Strep Throat Treatment Market
Strep Throat Treatment Market Forecasts to 2032 - Global Analysis By Treatment Type (Antibiotics, Pain Relievers, Probiotic Therapies, Herbal/Natural Remedies and Other Treatment Types), Route of Administration (Oral, Topical and Injectable), Disease Type, Distribution Channel, Diagnosis Method, End User and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $2.26 BN |
|
Projected Year Value (2032) |
US $3.88 BN |
|
CAGR (2025 - 2032) |
8.0% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Strep Throat Treatment Market is accounted for $2.26 billion in 2025 and is expected to reach $3.88 billion by 2032 growing at a CAGR of 8.0% during the forecast period. Strep throat treatment primarily involves the use of antibiotics to eliminate the Streptococcus pyogenes bacteria responsible for the infection. Commonly prescribed antibiotics include amoxicillin or penicillin, but patients with allergies may also be treated with cephalexin or azithromycin. The severity and duration of symptoms can be lessened, complications like rheumatic fever can be avoided, and the chance of infecting others is decreased with early antibiotic treatment. Moreover, supportive care can help manage symptoms like fever, inflammation, and sore throat. It includes rest, hydration, and over-the-counter pain relievers like acetaminophen or ibuprofen.
According to the Centers for Disease Control and Prevention (CDC), antibiotic treatment for group A streptococcal (GAS) pharyngitis is essential to reduce symptom duration, prevent complications, and limit transmission. Penicillin or amoxicillin is the recommended first-line therapy due to their efficacy, narrow spectrum, and low cost.
Market Dynamics:
Driver:
Growing streptococcal infection prevalence
Streptococcus pyogenes, also known as Group A Streptococcus or GAS, is the causative agent of strep throat, a common bacterial infection that primarily affects children between the ages of 5 and 15. The CDC estimates that millions of mild cases, such as strep throat, and between 11,000 and 24,000 cases of invasive GAS disease occur each year in the United States. In low- and middle-income nations where access to healthcare may be restricted, the burden is even greater globally. Additionally, the market for supportive therapies, diagnostics, and antibiotics is constantly active due to this enduring prevalence.
Restraint:
Over prescription and incorrect diagnosis of antibiotics
A major barrier to the market for strep throat treatments is the common misdiagnosis of sore throats. Antibiotics are often prescribed without adequate testing, even though many sore throats are viral rather than bacterial. The effectiveness of treatment is compromised because this not only results in needless drug use but also fuels antibiotic resistance. In outpatient settings in the United States, up to 30% of antibiotic prescriptions are unnecessary, according to the CDC. Furthermore, regulatory pressure and tighter prescription guidelines brought about by this over prescription can indirectly stifle market expansion by reducing the sale of indiscriminate antibiotics.
Opportunity:
Developments in at-home and quick diagnostics
The development of quick and at-home strep throat diagnostic kits has been prompted by the move toward self-testing and decentralization of care. Similar to home COVID-19 or pregnancy tests, consumers can now self-test for streptococcal infections using over-the-counter kits owing to developments in digital health and molecular diagnostics. Moreover, these developments facilitate early detection and treatment and lessen the strain on clinical infrastructure, particularly in isolated or resource-constrained locations. Businesses can take advantage of this expanding consumer-driven market by investing in diagnostic solutions that are easy to use, precise, and reasonably priced.
Threat:
Generic competition and market saturation
A small number of well-known antibiotics that have been used for decades dominate the market for strep throat treatments. There are inexpensive generic versions of many of these medications, including amoxicillin and penicillin. This deters significant pharmaceutical investment and innovation in this field by resulting in fierce price competition and narrow profit margins. Additionally, lack of unique products can impede market expansion and increase reliance on bulk purchasing agreements or public-sector tenders, which aren't always profitable.
Covid-19 Impact:
The COVID-19 pandemic affected the market for strep throat treatments. On the one hand, strep throat and other common respiratory infections have become much less common as a result of the widespread adoption of preventive measures like mask wearing, social distancing, and better hygiene. The pandemic, however, hastened the uptake of telemedicine and at-home diagnostic instruments, opening up new avenues for the diagnosis and prescription of strep throat remedies. Furthermore, the management and treatment of strep throat has also changed over time as a result of changes in prescribing practices and healthcare-seeking behaviour brought about by heightened public awareness of infectious diseases and antimicrobial stewardship.
The oral segment is expected to be the largest during the forecast period
The oral segment is expected to account for the largest market share during the forecast period. Due to their demonstrated effectiveness, simplicity of use, affordability, and high patient compliance, oral antibiotics—especially penicillin and amoxicillin—are the first-line treatment for strep throat. When it comes to outpatient treatment, the majority of patients—adults and children alike—prefer oral medications over inject able or topical ones. Since oral dosage forms like tablets, capsules, and suspensions are widely accessible and don't need a medical professional's supervision, they can be used even in environments with limited resources. Moreover, their widespread availability and ease of use help explain why they are so popular in the world of strep throat remedies.
The acute strep throat segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the acute strep throat segment is predicted to witness the highest growth rate. The rising incidence of Group A Streptococcus infections worldwide, especially in children and adolescents who are most susceptible to acute strep throat, is what is driving this segment's growth. The expansion of point-of-care testing and growing knowledge of early diagnosis and appropriate antibiotic treatment facilitate quicker acute infection detection and management. Additionally, in order to avoid complications like rheumatic fever and post-streptococcal glomerulonephritis, medical professionals are giving priority to acute cases, which raises the need for treatment.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, driven by a strong healthcare system, a high level of infectious disease awareness, and easy access to services for diagnosis and treatment. The high incidence of strep throat in the area, particularly in school-age children, contributes to the ongoing need for quick diagnostic tests and antibiotics. Market expansion is further supported by a strong institutional and governmental emphasis on routine health examinations, antibiotic stewardship, and early diagnosis. Furthermore, the availability and innovation of treatments are improved by the presence of top pharmaceutical companies and continuous research and development.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR because of its sizable and expanding population, increased knowledge of infectious diseases, and easier access to medical care. Strep throat and other respiratory tract infections are on the rise in countries like China, India, and Southeast Asia, especially in young people and the elderly. The market is expanding as a result of government efforts to improve primary healthcare, as well as increased access to antibiotics and healthcare outreach in rural areas. Additionally, the region's market is expanding quickly due to rising investments in telehealth, diagnostic infrastructure, and public health initiatives.
Key players in the market
Some of the key players in Strep Throat Treatment Market include Bayer AG, GSK plc (GlaxoSmithKline), Abbott Laboratories, Merck & Co., Inc., Pfizer Inc., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd, Melinta Therapeutics, Dr. Reddy's Laboratories Ltd., Azurity Pharmaceuticals, Inc., Mylan N.V. (Viatris), Sandoz, Cipla Ltd. and Sun Pharmaceutical Industries Ltd.
Key Developments:
In March 2025, Bayer and Suzhou Puhe BioPharma Co.,Ltd announced that they have entered into a global license agreement for Puhe BioPharma’s oral, small molecule PRMT5 inhibitor that selectively targets MTAP-deleted tumors. Under the agreement, Bayer obtains an exclusive worldwide license to develop, manufacture and commercialize the MTA-cooperative PRMT5 inhibitor.
In March 2025, Merck and Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that the companies have entered into an exclusive license agreement for HRS-5346, an investigational oral small molecule Lipoprotein(a), or Lp(a), inhibitor currently being evaluated in a Phase 2 clinical trial in China. Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.
In December 2024, Abbott Laboratories and DexCom they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.
Treatment Types Covered:
• Antibiotics
• Pain Relievers
• Probiotic Therapies
• Herbal/Natural Remedies
• Other Treatment Types
Route of Administrations Covered:
• Oral
• Topical
• Injectable
Disease Types Covered:
• Acute Strep Throat
• Pharyngitis
• Tonsillitis
• Laryngitis
• Other Disease Types
Distribution Channels Covered:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Diagnosis Methods Covered:
• Antibody Test
• Physical Examination
• Throat Culture
• Rapid Antigen Detection Tests (RADTs)
End Users Covered:
• Hospitals
• Specialty Clinics
• Diagnostic Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Strep Throat Treatment Market, By Treatment Type
5.1 Introduction
5.2 Antibiotics
5.2.1 Amoxicillin
5.2.2 Penicillin
5.3 Pain Relievers
5.4 Probiotic Therapies
5.5 Herbal/Natural Remedies
5.6 Other Treatment Types
6 Global Strep Throat Treatment Market, By Route of Administration
6.1 Introduction
6.2 Oral
6.3 Topical
6.4 Injectable
7 Global Strep Throat Treatment Market, By Disease Type
7.1 Introduction
7.2 Acute Strep Throat
7.3 Pharyngitis
7.4 Tonsillitis
7.5 Laryngitis
7.6 Other Disease Types
8 Global Strep Throat Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacy
8.3 Retail Pharmacy
8.4 Online Pharmacy
9 Global Strep Throat Treatment Market, By Diagnosis Method
9.1 Introduction
9.2 Antibody Test
9.3 Physical Examination
9.4 Throat Culture
9.5 Rapid Antigen Detection Tests (RADTs)
10 Global Strep Throat Treatment Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Specialty Clinics
10.4 Diagnostic Laboratories
10.5 Other End Users
11 Global Strep Throat Treatment Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Bayer AG
13.2 GSK plc (GlaxoSmithKline)
13.3 Abbott Laboratories
13.4 Merck & Co., Inc.
13.5 Pfizer Inc.
13.6 Novartis AG
13.7 Sanofi
13.8 Teva Pharmaceutical Industries Ltd
13.9 Melinta Therapeutics
13.10 Dr. Reddy's Laboratories Ltd.
13.11 Azurity Pharmaceuticals, Inc.
13.12 Mylan N.V. (Viatris)
13.13 Sandoz
13.14 Cipla Ltd.
13.15 Sun Pharmaceutical Industries Ltd.
List of Tables
1 Global Strep Throat Treatment Market Outlook, By Region (2024-2032) ($MN)
2 Global Strep Throat Treatment Market Outlook, By Treatment Type (2024-2032) ($MN)
3 Global Strep Throat Treatment Market Outlook, By Antibiotics (2024-2032) ($MN)
4 Global Strep Throat Treatment Market Outlook, By Amoxicillin (2024-2032) ($MN)
5 Global Strep Throat Treatment Market Outlook, By Penicillin (2024-2032) ($MN)
6 Global Strep Throat Treatment Market Outlook, By Pain Relievers (2024-2032) ($MN)
7 Global Strep Throat Treatment Market Outlook, By Probiotic Therapies (2024-2032) ($MN)
8 Global Strep Throat Treatment Market Outlook, By Herbal/Natural Remedies (2024-2032) ($MN)
9 Global Strep Throat Treatment Market Outlook, By Other Treatment Types (2024-2032) ($MN)
10 Global Strep Throat Treatment Market Outlook, By Route of Administration (2024-2032) ($MN)
11 Global Strep Throat Treatment Market Outlook, By Oral (2024-2032) ($MN)
12 Global Strep Throat Treatment Market Outlook, By Topical (2024-2032) ($MN)
13 Global Strep Throat Treatment Market Outlook, By Injectable (2024-2032) ($MN)
14 Global Strep Throat Treatment Market Outlook, By Disease Type (2024-2032) ($MN)
15 Global Strep Throat Treatment Market Outlook, By Acute Strep Throat (2024-2032) ($MN)
16 Global Strep Throat Treatment Market Outlook, By Pharyngitis (2024-2032) ($MN)
17 Global Strep Throat Treatment Market Outlook, By Tonsillitis (2024-2032) ($MN)
18 Global Strep Throat Treatment Market Outlook, By Laryngitis (2024-2032) ($MN)
19 Global Strep Throat Treatment Market Outlook, By Other Disease Types (2024-2032) ($MN)
20 Global Strep Throat Treatment Market Outlook, By Distribution Channel (2024-2032) ($MN)
21 Global Strep Throat Treatment Market Outlook, By Hospital Pharmacy (2024-2032) ($MN)
22 Global Strep Throat Treatment Market Outlook, By Retail Pharmacy (2024-2032) ($MN)
23 Global Strep Throat Treatment Market Outlook, By Online Pharmacy (2024-2032) ($MN)
24 Global Strep Throat Treatment Market Outlook, By Diagnosis Method (2024-2032) ($MN)
25 Global Strep Throat Treatment Market Outlook, By Antibody Test (2024-2032) ($MN)
26 Global Strep Throat Treatment Market Outlook, By Physical Examination (2024-2032) ($MN)
27 Global Strep Throat Treatment Market Outlook, By Throat Culture (2024-2032) ($MN)
28 Global Strep Throat Treatment Market Outlook, By Rapid Antigen Detection Tests (RADTs) (2024-2032) ($MN)
29 Global Strep Throat Treatment Market Outlook, By End User (2024-2032) ($MN)
30 Global Strep Throat Treatment Market Outlook, By Hospitals (2024-2032) ($MN)
31 Global Strep Throat Treatment Market Outlook, By Specialty Clinics (2024-2032) ($MN)
32 Global Strep Throat Treatment Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
33 Global Strep Throat Treatment Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
